Skip to main content
SpringerLink
Log in

Levosimendan in Regional Myocardial Ischemia

  • Editorial Introduction
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Figgitt DP, Gillies PS, Goa KL. Levosimendan. Drugs 2001;61:613–627.

    Google Scholar 

  2. Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J, Lindén IB. Cardiac troponin C as target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 1995;27:1859–1866.

    Google Scholar 

  3. Janssen PML, Datz N, Zeitz O, Hasenfuss G. Levosimendan improves dastolic and systolic function in failing human myocardium. Europ J Pharmacol 2000;404:191–199.

    Google Scholar 

  4. Hasenfuss G, Pieske B, Castell M, Kretschmann B, Maier LS, Just H. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation 1998;98:2141–2147.

    Google Scholar 

  5. Yokoshiki H, Katsube Y, Sunagawa M, et al. Levosimendan, a novel calcium sensitizer, activates the glibenclamidesensitive K+ channel in rat arterial myocytes. Eur J Pharmacol 1997;333:249–259.

    Google Scholar 

  6. Rump AFE, Acar D, Klaus W. A quantitative comparison of functional and anti-ischemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts. Br J Pharmacol 1994;112:757–762.

    Google Scholar 

  7. Kersten JR, Montgomery MW, Pagel PS, et al. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of KATP channels. Anesth Analg 2000;90:5–11.

    Google Scholar 

  8. Follath F, Cleland JGF, Just H, et al. Efficacy and safety of intravenus levosimendan in severe low-output heart failure. Circulation 1999;100(Suppl.I):I-646.

    Google Scholar 

  9. Slawsky MT, Colucci WS, Gottlieb SS, et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation 2000;102:2222–2227.

    Google Scholar 

  10. Nieminen MS, Akkila J, Hasenfuss G, et al. Hemodynamic and neurohumoral effects of continous infusion of levosimendan in patients with congestive heart failure. J amColl Cardiol 2000;36:1903–1912.

    Google Scholar 

  11. Du Toit E, Hofmann D, McCarthy J, Pineda C. Effect of levosimendan on myocardial contractility, coronary and peripheral blood flow, and arryrhtmia during coronary artery ligation and reperfusion in the in vivo pig model. Heart 2001;86:81–87.

    Google Scholar 

  12. Brown BG, Bolson EL, Dodge HT. Dynamic mechanisms in human coronary artery stenosis. Circulation 1984;70:917–922.

    Google Scholar 

  13. Lilleberg J, Nieminen MS, Akkila J, Heikkilä L, Kuitunen A, Lehtonen L, Verkkala K, Mattila S, Salmenperä M. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Europ Heart J 1998;19:660–668.

    Google Scholar 

  14. Zäll S, Milocco I, Rickstein SE. Effects of adenosine on myocardial blood flow and metabolism after coronary artery bypass surgery. Anaesth Analg 1991;73:689–695.

    Google Scholar 

  15. Nijhawan N, Nicolosi AC, Montgomery MW, et al. Levosimendan enhances cardiac performance after cardiopulmonary bypass: A prospective, randomized, placebo-controlled clinical trial. J Cardiovasc Pharmacol 1999;34:219–228.

    Google Scholar 

  16. Du Toit EF, Muller CA, McCarthy J, et al. Levosimendan: Effects of a calcium sensitizer on function and cyclic nucleotide levels during ischemia/reprefusion in the Langendorff perfused guinea pig heart. J Pharmacol Exp Ther 1999;290:505–514.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology and Pneumology, Georg-August-Universität Göttingen, Germany

    Burkert Pieske

Authors
  1. Burkert Pieske
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pieske, B. Levosimendan in Regional Myocardial Ischemia. Cardiovasc Drugs Ther 16, 379–381 (2002). https://doi.org/10.1023/A:1022199932485

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022199932485

Search

Navigation